LMH STRATEGIC SOLUTIONS

Lobbying for BICYCLE THERAPEUTICS · A clinical-stage biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $150,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.

Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.